Cofactor Genomics’s mission is to create diagnostics that have the ability to predict the patients that can benefit from immunotherapies. Using more insightful multidimensional biomarkers created with RNA and machine learning, Cofactor’s diagnostics offer greater predictive power than any current test. Instead of searching for isolated, single-analyte biomarkers or DNA mutations, Cofactor’s products create multidimensional biomarkers that better capture the complex immune response at the site of a tumor. Cofactor Genomics empowers clinicians to be better informed while making treatment decisions to improve patient outcomes.
| Website | https://cofactorgenomics.com |
| Employees | 13 (9 on RocketReach) |
| Founded | 2015 |
| Phone | +1 314-531-4647 |
| Industry | Biotechnology |
| Keywords | Cancer Diagnostics, Rna Biomarkers, Rna Sequencing, Machine Learning Diagnostics, Patient Stratification, Precision Oncology, Predictive Diagnostics, Molecular Diagnostics, Biomarker Discovery, Cancer Biomarkers, Liquid Biopsy, Genomic Diagnostics, Immuno-Oncology, Personalized Medicine, Clinical Diagnostics, Cancer Research |
| Competitors | Roche, Thermo Fisher Scientific, Illumina, Guardant Health, Bio-Rad Laboratories, QIAGEN, Oxford Nanopore Technologies, BGI Genomics, PacBio, Eurofins Genomics Americas +39 more (view full list) |
Looking for a particular Cofactor Genomics employee's phone or email?
Chris Parker is the CEO of Cofactor Genomics.
9 people are employed at Cofactor Genomics.